| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.095 | 0.001 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.008 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |